ramiprilat (Iris Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameramiprilat (Iris Pharma)
Drug Alias Nameramiprilat
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIris Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIris Pharma
Active IndicationsN/A
Inactive IndicationsStargardt Disease

Other Information

ATC CodeN/A
Related LinksN/A